A European devices agency: the case for
This article was originally published in Clinica
Do we need a European Medical Devices Agency? This perennial question has seemingly never been properly addressed, while at the same time never dropping off the unofficial agenda of national device experts and students of the industry, who have made this the focus of their work. But now the issue is being placed firmly on the table at EU level, as UK-based devices legal expert Christopher Hodges proposes that it is time to reflect whether a European Agency is needed by this sector
You may also be interested in...
A collaboration between Novo and Fauna will look at animal hibernation and genetic sequencing for hints toward novel therapies for obesity. Pfizer will use Insilico’s machine learning technology in target validation.
The introduction of gene therapies has been the highest-profile new modality to reach the market, but new RNA-based therapeutics hold significant potential and could be more accessible for patients. Scrip reviews the leading drug developers in this space.